The significant increase in net loss for Organigram from C$7.5 million to C$27.1 million year-over-year is a strong indicator of deteriorating financial health and operational challenges. This could lead to negative investor sentiment and a potential decrease in stock price in the short term as the market reacts to these worse-than-expected financial results.